why choose us

Clinical Trials Search

Showing 14,660 of 132,656 result(s)
Translation and Validation of the Arabic Version of the OHIP Questionnaire

Status: Completed

Condition: Oral Health

Interventions: Translated Arabic version of Oral Health Impact Profile questionnaire

Date: 2023-02-21

TaKeTiNa in the Treatment of Depression: a Pilot Study.

Status: Completed

Condition: Major Depressive Disorder

Interventions: TaKeTiNa music therapy uses a group to perform music together.
Each member of the group is needed for the synchronization of the whole group.

Date: 2023-02-21

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

Status: COMPLETED

Condition: Diabetes Mellitus, Type 2

Interventions: Concentrated rapid acting insulin aspart

Date: 2023-02-21

A Specific miRNA Encoded by SARS-CoV-2 as a Diagnostic Tool to Predict Disease Severity in COVID-19 Patients

Status: Completed

Condition: COVID-19

Interventions: Interventional

Date: 2023-02-21

Exercise Training Six-Months After Discharge in Post-COVID-19 Syndrome

Status: Completed

Condition: COVID-19 Pneumonia

Interventions: Interventional

Date: 2023-02-21

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Status: Completed

Condition: Anatomic Stage IV Breast Cancer AJCC v8

Interventions: Given IV

Date: 2023-02-21

Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy

Status: Completed

Condition: Coronary Allograft Vasculopathy (CAV)

Interventions: CardioFlux MCG is a process that observes incremental changes in the heart's electrical activity by the magnetic fields generated by these curren

Date: 2023-02-21

Phase I;IIa Study for AZD5335 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors

Status: Completed

Condition: Ovarian Cancer

Interventions: IV Antibody-drug conjugate

Date: 2023-02-21

A Study of Participants Ages 21-65 Diagnosed With Dyspareunia and the Effects of Low Intensity Shockwave Treatment

Status: Completed

Condition: Female Dyspareunia

Interventions: Treatment dose: 1,000 - 1,500 shocks, 2.5-3.0
Hz, 0.06-0.10
mJ;mm2 (Intensity of 6-8), 8 to 12 minutes

Date: 2023-02-21

Identify the Optimal TMS Target to Modulate Reward Activity

Status: Completed

Condition: Nicotine Use Disorder

Interventions: The active group will receive 10hz TMS stimulation.
Participants in the active stimulation group will receive10-Hz TMS to left DLPFC.
The LD

Date: 2023-02-21